Citigroup Inc Sc Pharmaceuticals Inc. Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
A detailed history of Citigroup Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Citigroup Inc holds 28,417 shares of SCPH stock, worth $92,355. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,417
Previous 6,177
360.05%
Holding current value
$92,355
Previous $26,000
396.15%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SCPH
# of Institutions
100Shares Held
38.3MCall Options Held
110KPut Options Held
12.1K-
Orbimed Advisors LLC San Diego, CA6.06MShares$19.7 Million0.65% of portfolio
-
Rubric Capital Management LP New York, NY4.78MShares$15.5 Million0.61% of portfolio
-
Aigh Capital Management LLC Baltimore, MD4.12MShares$13.4 Million7.6% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX2.86MShares$9.29 Million0.04% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.05MShares$6.66 Million0.37% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $89.1M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...